Medicare Announces GLP-1 Weight Loss Medication Pilot Program
Discover Medicare's new pilot program for weight loss medications, offering access to GLP-1 drugs for just $50/month, effective July 2026.
Discover Medicare's new pilot program for weight loss medications, offering access to GLP-1 drugs for just $50/month, effective July 2026.
Discover how recent Medicare Part D changes affect drug costs and access for seniors, influencing insurance strategies and patient financial planning.
Learn how to choose the best Medicare Part D plan for 2024. Understand costs, coverage, and the valuable tools available for decision-making.
CMS initiates a temporary coverage program for GLP-1 medications aiming to assist Medicare beneficiaries before full BALANCE Model implementation. Learn more.
Medicare Part D sees near-universal prior authorization and rising out-of-pocket costs for GLP-1 drugs in 2025, reflecting insurer adjustments to new cost and regulatory pressures.